Skip to main content Skip to main navigation menu Skip to site footer

Vitamin D supplementation in subjects with hypovitaminosis D: a randomized double-blind, placebo-controlled trial

  • Heri Nugroho ,
  • Tjokorda GDP ,
  • Tony Suhartono ,
  • Darmono Darmono ,

Abstract

Introduction: Despite having abundant sunshine all year long, hypovitaminosis D in Indonesia is still surprisingly prevalent. However, hypovitaminosis D in Indonesia has still been severely underdiagnosed and there were even fewer studies on its treatment. Thus, we aim to assess the effectiveness of daily vitamin D supplementation for subjects with hypovitaminosis D.

Method: A randomized double-blind, placebo-controlled trial conducted was conducted with a total of 76 healthy, non-obese, working-age participants with hypovitaminosis D. The intervention was daily 1,000 IU of vitamin D3 supplementation for 12 weeks, while the placebo group received a placebo pill. The serum 25(OH)D level was measured pre-intervention, after 4 weeks, and after 12 weeks of intervention. The data were analyzed using an unpaired t-test in SPSS version 24.0. Out of the 81 participants, a total of 76 participants (93.8%) have hypovitaminosis D.

Result: The serum 25(OH)D level in the treatment group was significantly higher than in the placebo group after 12 weeks of supplementation. The delta of serum 25(OH)D level after 12 weeks of supplementation was also significantly higher in the treatment group. Furthermore, the serum 25(OH)D level in the placebo group was found to be significantly reduced at the 12th week compared to the baseline. Participants who received daily supplementation of 1000 IU vitamin D3 for 12 consecutive weeks have significantly higher serum 25(OH)D levels than the participants in the placebo group. Same result was also observed when the changes of serum 25(OH)D after 12 weeks were analyzed.

Conclusion: Hypovitaminosis D was surprisingly very prevalent among the working-age group in Indonesia. Participants who received daily supplementation of 1000 IU vitamin D3 for 12 consecutive weeks have significantly higher serum 25(OH)D levels than the participants in the placebo group.

References

  1. Holick M. Vitamin D deficiency. N Engl J Med. 2007;357:266–81. http://dx.doi.org/10.1056/NEJMra070553
  2. Pittas AG, Lau J, Hu FB, Dawson-Hughes B. Review: The role of vitamin D and calcium in type 2 diabetes. A systematic review and meta-analysis. J Clin Endocrinol Metab. 2007;92(6):2017–29. http://dx.doi.org/10.1210/jc.2007-0298
  3. Giovannucci E, Liu Y, Rimm EB, Hollis BW, Fuchs CS, Stampfer MJ, et al. Prospective study of predictors of vitamin D status and cancer incidence and mortality in men. J Natl Cancer Inst. 2006;98(7):451–9. http://dx.doi.org/10.1093/jnci/djj101
  4. Dobnig H, Pilz S, Scharnagl H, Renner W, Seelhorst U. Independent Association of Low Serum. Arch Intern Med. 2008;168(12):1340–9. http://dx.doi.org/10.1001/archinte.168.12.1340
  5. Hewison M. Vitamin D and innate immunity. Curr Opin Investig Drugs. 2008;9:485–90. http://dx.doi.org/10.1016/j.mce.2010.02.013
  6. Melamed ML, Michos ED, Post W, Astor B. 25-hydroxyvitamin D levels and the risk of mortality in the general population. Obstet Gynecol Surv. 2008;63(12):781–2. http://dx.doi.org/10.1001/archinte.168.15.1629
  7. Rosen C. Vitamin D insufficiency. N Engl J Med. 2011;364(3):248–54. http://dx.doi.org/10.1056/NEJMcp1009570
  8. Naeem Z. Vitamin D deficiency: an ignored epidemic. International Journal of Health Science. Int J Heal Sci. 2010;4(1):V–VI.
  9. Forrest KYZ, Stuhldreher WL. Prevalence and correlates of vitamin D deficiency in US adults. Nutr Res. 2011;31(1):48–54. http://dx.doi.org/10.1016/j.nutres.2010.12.001
  10. Cashman KD, Dowling KG, Škrabáková Z, Gonzalez-Gross M, Valtueña J, De Henauw S, et al. Vitamin D deficiency in Europe: Pandemic?. Am J Clin Nutr. 2016;103(4):1033–44. http://dx.doi.org/10.3945/ajcn.115.120873
  11. Nimitphong H, Holick MF. Prevalence of Vitamin D Deficiency in Asia Vitamin D status and sun exposure in Southeast Asia. Dermatoendocrinol. 2013;5(1):34–7. http://dx.doi.org/10.4161/derm.24054
  12. Oemardi M, Horowitz M, Wishart JM, Morris HA, Need AG, O’Loughlin PD, et al. The effect of menopause on bone mineral density and bone-related biochemical variables in Indonesian women. Clin Endocrinol (Oxf). 2007;67(1):93–100. http://dx.doi.org/10.1111/j.1365-2265.2007.02844.x
  13. Setiati S, Oemardi M, Sutrisna B, Supartondo. The role of ultraviolet-B from sun exposure on vitamin D3 and parathyroid hormone level in elderly women in Indonesia. Asian J Gerontol Geriatr. 2007;2:126–58.
  14. Green TJ, Skeaff CM, Rockell JEP, Venn BJ, Lambert A, Todd J, et al. Vitamin D status and its association with parathyroid hormone concentrations in women of child-bearing age living in Jakarta and Kuala Lumpur. Eur J Clin Nutr. 2008;62(3):373–8. http://dx.doi.org/10.1038/sj.ejcn.1602696
  15. Holick MF, Binkley NC, Bischoff-Ferrari HA, Gordon CM, Hanley DA, Heaney RP, et al. Evaluation, treatment, and prevention of vitamin D deficiency: An endocrine society clinical practice guideline. J Clin Endocrinol Metab. 2011;96(7):1911–30. http://dx.doi.org/10.1210/jc.2011-0385
  16. Hossein-Nezhad A, Holick MF. Vitamin D for health: A global perspective. Mayo Clin Proc. 2013;88(7):720–55. http://dx.doi.org/10.1016/j.mayocp.2013.05.011
  17. Cashman KD, Ritz C, Kiely M. Improved dietary guidelines for vitamin D: Application of individual participant data (IPD)-level meta-regression analyses. Nutrients. 2017;9(5). http://dx.doi.org/10.3390/nu9050469
  18. Holvik K, Madar AA, Meyer HE, Lofthus CM, Stene LC. Changes in the vitamin D endocrine system and bone turnover after oral vitamin D3 supplementation in healthy adults: Results of a randomized trial. BMC Endocr Disord. 2012;12:14-19. http://dx.doi.org/10.1186/1472-6823-12-7
  19. Barnes MS, Robson PJ, Bonham MP, Strain JJ, Wallace JMW. Effect of vitamin D supplementation on vitamin D status and bone turnover markers in young adults. Eur J Clin Nutr. 2006;60(6):727–33. http://dx.doi.org/10.1038/sj.ejcn.1602374
  20. Biancuzzo RM, Clarke N, Reitz RE, Travison TG, Holick MF. Serum concentrations of 1,25-dihydroxyvitamin D2 and 1,25-dihydroxyvitamin D3 in response to vitamin D2 and vitamin D3 supplementation. J Clin Endocrinol Metab. 2013;98(3):973–9.
  21. Holick MF, Biancuzzo RM, Chen TC, Klein EK, Young A, Bibuld D, et al. Vitamin D2 is as effective as vitamin D3 in maintaining circulating concentrations of 25-hydroxyvitamin D. J Clin Endocrinol Metab. 2008;93(3):677–81. http://dx.doi.org/10.1210/jc.2012-2114
  22. Yosephin B. Sun exposure and vitamin D-calcium supplementation and its effect on 25-hydroxyvitamin D serum, blood pressure and lipid profiles of women of childbearing age. 2014; http://repository.ipb.ac.id/handle/123456789/7451
  23. Cashman KD. Vitamin D requirements for the future—lessons learned and charting a path forward. Nutrients. 2018;10(5):19-23. http://dx.doi.org/10.3390/nu10050533
  24. Zittermann A, Ernst JB, Prokop S, Fuchs U, Dreier J, Kuhn J, et al. Effect of Vitamin D on all-causemortality in heart failure (EVITA): A 3-year randomized clinical trial with 4000 IU Vitamin D daily. Eur Heart J. 2017;38(29):2279–86. http://dx.doi.org/10.1093/eurheartj/ehx235
  25. Lukaszuk JM, Luebbers PE. 25(OH)D status: Effect of D3 supplement. Obes Sci Pract. 2017;3(1):99–105. http://dx.doi.org/10.1002/osp4.85

How to Cite

Nugroho, H., GDP, T., Suhartono, T., & Darmono, D. (2021). Vitamin D supplementation in subjects with hypovitaminosis D: a randomized double-blind, placebo-controlled trial. Bali Medical Journal, 10(1), 405–406. https://doi.org/10.15562/bmj.v10i1.2230

HTML
10

Total
24

Share

Search Panel